Categories AlphaGraphs, Consumer, Earnings, Health Care

Johnson & Johnson (JNJ) reports Q4 2021 earnings

Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2021 financial results before the regular market hours on Tuesday.

The pharmaceutical giant reported revenue of $24.8 billion, up 10.4% year-over-year, with operational growth of 11.6%

Net earnings of $4.7 billion or $1.77 per share increased by 172%, exceeding the target that analysts had anticipated.

Most Popular

Beyond short-term challenges, Cisco’s (CSCO) prospects remain intact

Cisco Systems Inc. (NASDAQ: CSCO) is the undisputed leader in networking technology, but its core business has been facing challenges over the past few years. While the company faces stiff

Earnings: Applied Materials (AMAT) Q2 profit, revenue increase

Semiconductor technology company Applied Materials, Inc. (NASDAQ: AMAT) on Thursday reported higher earnings and revenues for the second quarter of 2022. However, the results missed analysts' estimates. Adjusted net income

Target (TGT) expects Q1 headwinds to continue to impact profitability in the near term

Shares of Target Corporation (NYSE: TGT) were down 4% on Thursday, yet to fully recover from the beating it took a day earlier after delivering mixed results for the first

Add Comment
Viewing Highlight